Electroencephalographic effects induced by choline pivaloyl esters in scopolamine-treated or nucleus basalis magnocellularis lesioned rats

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 4, 2004, Pages 667-673

  Rispoli, Vincenzo ^a   Rotiroti, Domenicantonio ^a   Carelli, Vincenzo ^b   Liberatore, Felice ^b   Scipione, Luigi ^b   Marra, Rosario ^c   Tortorella, Silvano ^b   Di Rienzo, Barbara ^b  

^a Department of Pharmacobiological Sciences   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

AChE Inhibitors; Cholinergic neurotransmission; Electroencephalography; Lesioned nucleus basalis magnocellularis

Indexed keywords

[2 (2,2 DIMETHYLPROPIONYLOXY)ETHYL]TRIMETHYLAMMONIUM 2,2 DIMETHYLPROPIONATE; [2 (2,2 DIMETHYLPROPIONYLOXY)ETHYL]TRIMETHYLAMMONIUM IODIDE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTER DERIVATIVE; SCOPOLAMINE; TACRINE; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHOLINERGIC TRANSMISSION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; FREQUENCY MODULATION; MAGNOCELLULAR NUCLEUS; MALE; NEUROTRANSMISSION; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BASAL NUCLEUS OF MEYNERT; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ESTERS; INJECTIONS, INTRAPERITONEAL; MALE; PARASYMPATHETIC NERVOUS SYSTEM; PARASYMPATHOLYTICS; PARIETAL LOBE; RATS; RATS, WISTAR; SCOPOLAMINE;

ANIMALIA;

EID: 3843095052     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.04.031     Document Type: Article

References (28)

1. Brenner R.P., Reynolds C.F., Ulrich R.F. Diagnostic efficacy of computerized spectral versus visual EEG analysis in elderly normal, demented and depressed subjects. Electroencephalogr. Clin. Neurophysiol. 69(2):1988;110-117
2. Carelli V, Liberatore F, Scipione L, Rotiroti D, Rispoli V, Cardellini M, Choline derivatives for the treatment of Alzheimer's disease. Patent IT MI 2000 A000898- 21-4-2000, EP 1925883.9- 10-4-2001; C.A. 2001; 135(24):344212m.
3. Casamenti F., Deffenu G., Abbamondi A.L., Pepeu G. Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res. Bull. 16(5):1986;689-695
4. Doody R.S., Stevens J.C., Beck C., Dubinsky R.M., Kaye J.A., Gwyther L., et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurobiology. 56(9):2001;1154-1166
5. Elmstahl S., Rosen I., Gullberg B. Quantitative EEG in elderly patients with Alzheimer's disease and healthy controls. Dementia. 5(2):1994;119-124
6. Giacobini E. Cholinesterase inhibitors stabilize Alzheimer's disease. Ann. N.Y. Acad. Sci. 920:2000;321-327
7. Grutzendler I., Morris I.C. Cholinesterase inhibitors for Alzheimer's disease. Drugs. 61:2001;41-52
8. Helkala E.L., Laulumaa V., Soikkeli R., Partanen J., Soininen H., Riekkinen P.J. Slow-wave activity in the spectral analysis of the electroencephalogram is associated with cortical dysfunctions in patients with Alzheimer's disease. Behav. Neurosci. 105(3):1991;409-415
9. Katzman R. Medicinal progress in Alzheimer's disease. N. Engl. J. Med. 314:1986;964-973
10. Kuskowski M.A., Mortimer J.A., Morley G.K., Malone S.M., Okaya A.J. Rate of cognitive decline in Alzheimer's disease is associated with EEG alpha power. Biol. Psychiatry. 33(8-9):1993;659-662
11. Lo Conte G., Casamenti F., Bigl V., Milaneschi E., Pepeu G. Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch. Ital. Biol. 120(1-3):1982;176-188
12. Lopez O.L., Brenner R.P., Becker J.T., Ulrich R.F., Boller F., De Kosky S.T. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology. 48(6):1997;1521-1525
13. Miyauchi T., Hagimoto H., Ishii M., Endo S., Tanaka K., Kajiwara S., et al. Quantitative EEG in patients with presenile and senile dementia of the Alzheimer type. Acta Neurol. Scand. 89(1):1994;56-64
14. Muir J.L., Page K.J., Sirinathsinghji D.J.S., Robbins T.W., Everitt B.J. Excitotoxic lesion of basal forebrain cholinergic neurons: effects on learning, memory and attention. Behav. Brain Res. 57:1993;123-131
15. Paxinos G., Watson C. The Rat Brain in the Stereotaxic Coordinates. 1980;Academic Press, New York
16. Perry E.K., Perry R.H., Blessed G., Tomlison B.E. Changes in brain cholinesterases in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 4:1978;273-277
17. Pozzi D., Petracchi M., Sabe L., Golimstock A., Garcia H., Starkstein S. Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. 7(1):1995;61-67
18. Riekkinen P. Jr., Jakala P., Sirvio J. The effect of THA on scopolamine and nucleus basalis lesion-induced EEG slowing. Brain Res. Bull. 26:1991;633-637
19. Rispoli V., Rotiroti D., Carelli V., Liberatore F., Scipione L., Marra R., et al. Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or lesions of the nucleus basalis of Meynert. Neurosci. Lett. 356:2004;199-202
20. Schreiter-Gasser U., Gasser T., Ziegler P. Quantitative EEG analysis in early onset Alzheimer's disease: a controlled study. Electroencephalogr. Clin. Neurophysiol. 86(1):1993;15-22
21. Soininen H., Partanen J., Paakkonen A., Koivisto E., Riekkinen P.J. Changes in absolute power values of EEG spectra in the follow-up of Alzheimer's disease. Acta Neurol. Scand. 83(2):1991;133-136
22. Stam C.J., Jelles B., Achtereekte H.A., van Birgelen J.H., Slaets J.P. Diagnostic usefulness of linear and nonlinear quantitative EEG analysis in Alzheimer's disease. Clin. Electroencephalogr. 27(2):1996;69-77
23. Stewart D.J., MacFabe D.F., Vanderwolf C.H. Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res. 322(2):1984;219-232
24. Sunderland T., Tariot P., Murphy D.L., Weingartner H., Mueller E.A., Cohen R.M. Scopolamine challenges in Alzheimer's disease. Psychopharmacology (Berl.). 87(2):1985;247-249
25. Terry R., Katzman R. Dementia of the Alzheimer type: defining a disease. Bick K.L., Katzman R., Terry R.D. Alzheimer's disease. 1994;51-84 Raven, New York
26. Walen P.J., Kapp B.S., Pascoe J.P. Neuronal activity within the nucleus basalis and conditioned neocortical electroencephalographic activation. J. Neurosci. 14(3 Pt. 2):1994;1623-1633
27. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10(2):1981;122-126
28. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215(4537):1982;1237-1239